| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/16/2004 | WO2004108950A2 Methods for incorporating non-perfectly matched oligonucleotides into target-specific hybridization sequences |
| 12/16/2004 | WO2004108949A1 Biosensor having a silicone surfactant coated mesh layer |
| 12/16/2004 | WO2004108948A2 Systems, methods and kits for characterizing phosphoproteomes |
| 12/16/2004 | WO2004108945A2 Oligonucleotide modulation of cell adhesion |
| 12/16/2004 | WO2004108939A2 Bav packaging regions and e1 transcriptional control regions |
| 12/16/2004 | WO2004108932A1 Bacteria with increased levels of protein secretion, nucleotide sequences coding for a seca protein with increased levels of protein secretion, and method for producing proteins |
| 12/16/2004 | WO2004108930A1 Genes participating in fgf signal transduction |
| 12/16/2004 | WO2004108921A1 Method of nucleic acid infusion |
| 12/16/2004 | WO2004108918A1 Immobilization support, process for producing the same, electrode, process for producing the same, electrode reaction utilizing apparatus and process for producing the same |
| 12/16/2004 | WO2004108902A2 Biocompatible fluorescent silicon nanoparticles |
| 12/16/2004 | WO2004108899A2 Pni microarray and uses |
| 12/16/2004 | WO2004108896A2 Gene expression profiling of uterine serous papillary carcinomas and ovarian serous papillary tumors |
| 12/16/2004 | WO2004108891A2 Methods for screening inhibitors of apoptosis |
| 12/16/2004 | WO2004108883A2 Transducible dna-binding proteins |
| 12/16/2004 | WO2004108840A2 Nucleotides for prevention and treatment of bacterial and fungal pathologies |
| 12/16/2004 | WO2004108755A2 Chimeric adenovirus capsid proteins |
| 12/16/2004 | WO2004108081A2 Oligonucleotide synthesis with alternative solvents |
| 12/16/2004 | WO2004108065A2 Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies |
| 12/16/2004 | WO2004108009A2 Method and kit for assessing risk for bovine respiratory disease |
| 12/16/2004 | WO2004107958A2 Sterol markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
| 12/16/2004 | WO2004097034A3 Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 4 (tmprss4) |
| 12/16/2004 | WO2004094987A8 Kit for detecting endotoxin in aqueous solutions |
| 12/16/2004 | WO2004090115A3 Renilla gfp mutants with increased fluorescent intensity and special shift |
| 12/16/2004 | WO2004087955A8 Markers for roscovitine |
| 12/16/2004 | WO2004086041A3 Universal readout for target indentification using biological microarrays |
| 12/16/2004 | WO2004085679A3 Screens for altered immune responses due to mutations in the gene encoding cd45 |
| 12/16/2004 | WO2004081520A3 Optically decodable microcarriers, arrays and methods |
| 12/16/2004 | WO2004080448A3 Use of nep-associated molecules for treating non-immunogenic, non-hypertensive civilisation diseases |
| 12/16/2004 | WO2004080374A3 Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c) |
| 12/16/2004 | WO2004078940A3 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF eIF-5A1 |
| 12/16/2004 | WO2004075861A3 Recombinant adeno-associated virus production |
| 12/16/2004 | WO2004072252A3 Polymerase-based protocols for the introduction of deletions and insertions |
| 12/16/2004 | WO2004072245A3 Polymerase-based protocols for the introductions of deletions and insertions |
| 12/16/2004 | WO2004064735A3 Treatment of benign prostatic hyperplasia |
| 12/16/2004 | WO2004063699A3 Rapid detection of microorganisms |
| 12/16/2004 | WO2004063322A3 Dna size markers and method for preparing them |
| 12/16/2004 | WO2004061423A3 Compositions and methods for diagnosing and treating colon cancers |
| 12/16/2004 | WO2004060832B1 Fluorescent creatinine assay |
| 12/16/2004 | WO2004042344A3 Fabrication of a high resolution biological molecule detection device with gold electrical conductors |
| 12/16/2004 | WO2004037907A3 Luminescent metal ion complexes |
| 12/16/2004 | WO2004033622A9 Preservation of rna and morphology in cells and tissues |
| 12/16/2004 | WO2004003156A3 Il-21 as a regulator of immunoglobin production |
| 12/16/2004 | WO2003104434A3 A method to amplify variable sequences without imposing primer sequences |
| 12/16/2004 | WO2003092582B1 Chimeric ebola virus envelopes and uses therefor |
| 12/16/2004 | WO2003091407A3 Device and method for high-throughput quantification of mrna from whole blood |
| 12/16/2004 | WO2003080823A8 Bacteriophages useful for therapy and prophylaxis of bacterial infections |
| 12/16/2004 | WO2003068932A3 Method for crystallizing human gsk3 and novel crystal structure thereof |
| 12/16/2004 | WO2003066802A9 Gene expression analysis using nicking agents |
| 12/16/2004 | WO2003056343B1 Method for protein expression analysis |
| 12/16/2004 | WO2003054184A9 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
| 12/16/2004 | US20040255347 Using site specific recombination to insert heterologous nucleotide sequences into plants tissue; enhancing nutrient quality of plants; bioreactors |
| 12/16/2004 | US20040254737 Information processing apparatus, information processing method, storage medium and program |
| 12/16/2004 | US20040254363 Genes and snps associated with eating disorders |
| 12/16/2004 | US20040254362 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease |
| 12/16/2004 | US20040254360 Molecular identification of staphylococcus-type bacteria |
| 12/16/2004 | US20040254355 Labeling reagents comprising aphenylic analogs of rhodamine dyes |
| 12/16/2004 | US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders |
| 12/16/2004 | US20040254349 Mycobacterial antigens expressed under low oxygen tension |
| 12/16/2004 | US20040254346 Human survivin interacting protein 1 (sip-1) |
| 12/16/2004 | US20040254342 Substrates and assays for beta-secretase |
| 12/16/2004 | US20040254341 Human aspartyl protease peptide for use in identifying modulators for treatment and prevention of neurodegenerative and nervous system disorders; enzyme inhibitors |
| 12/16/2004 | US20040254153 Potentiation adenosine 3',5'-cyclic monophosphate in urogenital system of female |
| 12/16/2004 | US20040254140 Method for selective inactivation of viral replication |
| 12/16/2004 | US20040254135 Administering enzyme inhibitor; moderate metabolism |
| 12/16/2004 | US20040254134 Modulating heart cells; administering polynucleotide; adjust contraction |
| 12/16/2004 | US20040254132 Ovary-specific genes and proteins |
| 12/16/2004 | US20040254116 Contactor tissue with transforming growth factor kinase receptors; modulate cell proliferation |
| 12/16/2004 | US20040254110 Methods for diagnosing and treating Alzheimer's disease |
| 12/16/2004 | US20040254104 Genotype gene; determination polymorphism |
| 12/16/2004 | US20040253739 Detection procedures for fibrinogen and/or fibrinogen derivatives |
| 12/16/2004 | US20040253731 Solution comprising surfactant, hydrophobic phase and hydrophilic phase comprising plurality of microcapsules containing functional in vitro eukaryotic expression system for transfer of heterologous into cells |
| 12/16/2004 | US20040253730 Identifying modulators which induce apoptosis and activate cell cycle checkpoint systems; for use in treatment and prevention of cell proliferative disorders |
| 12/16/2004 | US20040253729 Circular site-directed mutagenesis |
| 12/16/2004 | US20040253727 Using both insertional and physiochemical means to generate stable, genetic rearrangement in cells; tissue engineering |
| 12/16/2004 | US20040253726 Caged compound cleaving process |
| 12/16/2004 | US20040253723 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 12/16/2004 | US20040253711 Mycobacterial genes down-regulated during latency |
| 12/16/2004 | US20040253706 Substrates and assays for beta-secretase |
| 12/16/2004 | US20040253702 Variants of beta-glucosidases |
| 12/16/2004 | US20040253698 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/16/2004 | US20040253686 Novel human kunitz-type inhibitors and methods relating thereto |
| 12/16/2004 | US20040253685 eNOS mutations useful for gene therapy and therapeutic screening |
| 12/16/2004 | US20040253684 Nucleotide sequences coding mambrane associated guanylate kinase for use in treatment and prevention of nervous system, blood, sleep and behavioral disorders |
| 12/16/2004 | US20040253682 Immunloglobulin prostaglandin inhibitor for use in the treatment and prevention of arthritic and inflammatory bowel disorders |
| 12/16/2004 | US20040253681 Mitogenic oxygenase regulators |
| 12/16/2004 | US20040253675 Method for GPCR assay with a coexpressed Galpha protein |
| 12/16/2004 | US20040253667 Expression vector comprising nuclelotide sequences coding membrane protein for use in identifying modulator for treatment of cell proliferative, nervous system and inflammatory diseases |
| 12/16/2004 | US20040253666 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/16/2004 | US20040253660 Identifying organisms grown on chromagenic semisolid nutrient media using digitized electrical signal; electronic libraries and storage |
| 12/16/2004 | US20040253659 Method for identification of glycosylated polypeptides |
| 12/16/2004 | US20040253658 Monitoing novel kinase activity via change in adenosine triphosphate concentration and bioluminescence in presence of kinase and phosphorylatable substrate; bioassay |
| 12/16/2004 | US20040253651 Detected from secreted glycoprotein (such as matrix metalloproteinases, prostate specific antigen, kallikrein 2, human chorionic gonadotrophin or carcinoembryonic antigen); glycosyltransferases; for diagnosing and targeting cell proliferative disorders; vaccines |
| 12/16/2004 | US20040253647 Evaluating modulators effectiveness as treatment for alzheimer's via quantifying amyloid precursor protein peptide cleavage products present after exposure agonist/antagonist |
| 12/16/2004 | US20040253642 Using multizonal bioassay to screen compounds singly or in combination, so as to, monitor safety, pharmacological and/or toxicity profiles of test compounds; drug screening |
| 12/16/2004 | US20040253639 Microorganism implicated in intestinal diseases, alzheimer's disease and other diseases |
| 12/16/2004 | US20040253631 Expression vector comprising topisomerase site-specific recombination sequences for use as gene transfer and propagation tools in bioreactors; gene therapy; protein and gene expression analysis |
| 12/16/2004 | US20040253627 System and method for multidimensional evaluation of combinations of compositions |
| 12/16/2004 | US20040253625 Identifying sequences differing by one or more single base changes, insertions, deletions, or translocations in a plurality of target nucleotide sequences; for use in disease diagnosis, food safety monitoring and forensics |
| 12/16/2004 | US20040253624 Contacting microporous material (ceramic, carbon, glass, metal, or metal oxide) with tin compound to produce composite, then contacting with pigment comprising elemental metal, metal oxide, and/or alloy; for hybridizing nucleic acids; solid phase synthesis |
| 12/16/2004 | US20040253623 Nucleic acid binding proteins |